Back to search
Inclusion Body Myositis, Sporadic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis, Sporadic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis, Sporadic trials you may qualify forTo evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM
Refer to the "Detailed Description" section.
This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits t…
This is a pilot study (phase 1 clinical trial) to evaluate the safety and tolerability of phenylbutyrate in IBM. In this open label study, 10 patients with spor…
The investigators are performing a gene therapy clinical trial in Becker muscular dystrophy (BMD) and sporadic inclusion body myositis (sIBM) patients. Both of…